MIDLOTHIAN, Va., March 1 Today, PARI Respiratory Equipment launched their newest aerosol delivery system, the Vios. Paired with PARI's gold standard reusable nebulizers, Vios delivers fast treatments, ...
MONTEREY, Calif., Nov. 10 PARI Pharma GmbH hassuccessfully completed Phase I and Phase II clinical trials comparing itsproprietary PARI Tobramycin 100 (150mg/1.5mL) formulation delivered via ...
RICHMOND, Va., Jan. 26, 2015 /PRNewswire/ -- The eRapid Nebulizer System (eRapid) from PARI has been approved as the first electronic nebulizer by the Food and Drug Administration to deliver Genentech ...
“We are pleased to serve thousands of home healthcare companies, medical supply distributors, pharmacies, hospitals, and physicians. Our customers share our commitment to providing the highest quality ...
Kitabis Pak (tobramycin inhalation solution) is now on the Preferred Drug List (PDL) for many state programs, expanding its access for patients with cystic fibrosis (CF) using nebulized antibiotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback